You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ABCA3 gene

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ABCA3 Gene and RDS in Late Preterm and Term Infants

Completed
Has Results
  • Respiratory Distress Syndrome, Newborn
  • no intervention
  • Chongqing, Chongqing, China
    Children's hospital of Chongqing Medical University
Jul 15, 2021

Plaquenil -Induced Retinal Toxicity, With Evaluation of ABCA4

Recruiting
  • Genotype
  • Retinal Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 27, 2023

    Iron, Alpha-Synuclein, and Lymphocyte-activation Gene-3 in

    Not yet recruiting
    • Brain Ischemia
    • Serum Iron
    • +7 more
    • Aswan, Egypt
      Aswan University Hospital
    Mar 7, 2023

    Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts

    Not yet recruiting
    • Warts
    • Detection of expression of SOCS3 gene
    • +2 more
    • (no location specified)
    Mar 12, 2023

    Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients Trial in Assiut (Quantitative Real Time Polymerase chain

    Recruiting
    • Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients
    • Quantitative Real Time Polymerase chain reaction (qRT-PCR)
    • ELISA and colorimeter
    • Assiut, Egypt
      Biochemistry department,Faculty of medicine
    Oct 10, 2023

    Gene Editing as a Therapeutic Approach for Rett Syndrome

    Recruiting
    • Rett Syndrome
    • Gene editing in vitro
    • Siena, Italy
      University of Siena
    Feb 13, 2023

    Age-Related Macular Degeneration Trial in Toronto (NG101 AAV gene therapy)

    Not yet recruiting
    • Age-Related Macular Degeneration
    • NG101 AAV gene therapy
    • Toronto, Ontario, Canada
      Vitreous Retina Macula Specialists of Toronto
    Aug 2, 2023

    Gaucher Disease, Type 3 Trial (Gene therapy, Enzyme Replacement Agent)

    Not yet recruiting
    • Gaucher Disease, Type 3
    • Gene therapy
    • Enzyme Replacement Agent
    • (no location specified)
    Apr 14, 2023

    Esophageal Tumors Trial (KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method))

    Not yet recruiting
    • Esophageal Neoplasms
    • KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method)
    • (no location specified)
    Dec 25, 2022

    Sickle Cell Disease Trial in Paris (DREPAGLOBE drug product)

    Active, not recruiting
    • Sickle Cell Disease
    • DREPAGLOBE drug product
    • Paris, France
      Department of Biotherapy, Necker-Enfants Malades Hospital
    Sep 26, 2022

    FGFR1 Gene Amplification, FGFR1 Gene Mutation, FGFR1 Gene Translocation Trial in United States (Pemigatinib, Quality-of-Life

    Active, not recruiting
    • FGFR1 Gene Amplification
    • +18 more
    • Scottsdale, Arizona
    • +5 more
    Oct 18, 2022

    NSCLC, Pancreatic Cancer, Locally Advanced Solid Tumor Trial in Sydney (HMBD-001, Docetaxel, Nab-paclitaxel)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • +3 more
    • Sydney, New South Wales, Australia
      GenesisCare North Shore
    Jun 16, 2023

    CLN3, Batten Disease Trial in Columbus (AT-GTX-502)

    Active, not recruiting
    • CLN3
    • Batten Disease
    • AT-GTX-502
    • Columbus, Ohio
      Nationwide Children's Hospital
    Jul 18, 2022

    Serum Interleukin 10 in Patients With ITP

    Recruiting
    • Thrombocytopenia
    • Serum IL10 By ELISA
    • +2 more
    • Sohag, Egypt
      Faculty Of Medicine
    Oct 24, 2022

    Hepatocellular Carcinoma Trial (GNB4 and Riplet Gene Methylation Combined Detection Kit (Fluorescent PCR Method))

    Not yet recruiting
    • Hepatocellular Carcinoma
    • GNB4 and Riplet Gene Methylation Combined Detection Kit (Fluorescent PCR Method)
    • (no location specified)
    Dec 25, 2022

    Lentiviral-based Gene-edited Immune Cell Therapy

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • +4 more
    • Pell's lentiviral-based gene-edited immune cell therapy
    • Kaohsiung, Taiwan
    • +2 more
    Oct 25, 2022

    Panel of Bacterial Gene Markers for Colorectal Advanced

    Recruiting
    • Colorectal Cancer
    • +2 more
    • Fecal immunochemical test (FIT)
    • Hong Kong, Hong Kong
      Prince of Wales Hospital
    Jul 19, 2022

    Serial Gut Microbiome and Bacterial Gene Markers Changes After

    Recruiting
    • Colorectal Cancer
    • +2 more
    • Bacterial gene markers test
    • Shatin, New Territories, Hong Kong
      Prince of Wales Hospital
    Oct 19, 2022

    Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation, Vascular Malformations Trial in Parkville (Alpelisib,

    Not yet recruiting
    • Slow-Flow Vascular Malformation
    • +17 more
    • Parkville, Victoria, Australia
      The Royal Children's Hospital
    Aug 7, 2023

    HIV-1 Infections Trial in Washington (HAART, T cells)

    Completed
    • HIV-1 Infections
    • Washington, District of Columbia
      Walter Reed Army Medical Center
    Aug 17, 2022

    Hemophilia B Trial (CSL222 (AAV5-hFIXco-Padua))

    Not yet recruiting
    • Hemophilia B
    • CSL222 (AAV5-hFIXco-Padua)
    • (no location specified)
    Aug 14, 2023

    Treatment of Symptoms of Grade 2 and Grade 3 Late Xerostomia From Salivary Gland Hypofunction Caused by Radiotherapy for Cancer

    Recruiting
    • Treatment of Symptoms of Grade 2 and Grade 3 Late Xerostomia From Salivary Gland Hypofunction Caused by Radiotherapy for Cancer of the Oropharynx
    • AAV2-hAQP1 Concentration 1
    • +2 more
    • Charlotte, North Carolina
      Atrium Health
    Jun 22, 2023

    FLT3-ITD Gene Mutation and CD135 Expression in Acute Myeloid

    Not yet recruiting
    • Acute Myeloid Leukemia
      • (no location specified)
      May 17, 2022

      CBD, Transplant Complication, Kidney Disease, Chronic Trial (Tacrolimus single dose, Epidiolex single dose, Epidiolex

      Not yet recruiting
      • CBD
      • +2 more
      • Tacrolimus single dose
      • +2 more
      • (no location specified)
      Aug 4, 2022

      Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

      Recruiting
      • Advanced Malignant Solid Neoplasm
      • +9 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 25, 2022